192 related articles for article (PubMed ID: 17644305)
21. Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model.
Donadon I; Pinotti M; Rajkowska K; Pianigiani G; Barbon E; Morini E; Motaln H; Rogelj B; Mingozzi F; Slaugenhaupt SA; Pagani F
Hum Mol Genet; 2018 Jul; 27(14):2466-2476. PubMed ID: 29701768
[TBL] [Abstract][Full Text] [Related]
22. Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia.
Ibrahim EC; Hims MM; Shomron N; Burge CB; Slaugenhaupt SA; Reed R
Hum Mutat; 2007 Jan; 28(1):41-53. PubMed ID: 16964593
[TBL] [Abstract][Full Text] [Related]
23. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Jun; 306(1):303-9. PubMed ID: 12788105
[TBL] [Abstract][Full Text] [Related]
24. Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation.
Lefler S; Cohen MA; Kantor G; Cheishvili D; Even A; Birger A; Turetsky T; Gil Y; Even-Ram S; Aizenman E; Bashir N; Maayan C; Razin A; Reubinoff BE; Weil M
PLoS One; 2015; 10(10):e0138807. PubMed ID: 26437462
[TBL] [Abstract][Full Text] [Related]
25. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.
Gold-von Simson G; Leyne M; Mull J; Rolnitzky LM; Goldberg JD; Berlin D; Axelrod FB; Slaugenhaupt SA
Pediatr Res; 2008 Feb; 63(2):186-90. PubMed ID: 18091349
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.
Hims MM; Ibrahim EC; Leyne M; Mull J; Liu L; Lazaro C; Shetty RS; Gill S; Gusella JF; Reed R; Slaugenhaupt SA
J Mol Med (Berl); 2007 Feb; 85(2):149-61. PubMed ID: 17206408
[TBL] [Abstract][Full Text] [Related]
27. Deletion of exon 20 of the Familial Dysautonomia gene Ikbkap in mice causes developmental delay, cardiovascular defects, and early embryonic lethality.
Dietrich P; Yue J; E S; Dragatsis I
PLoS One; 2011; 6(10):e27015. PubMed ID: 22046433
[TBL] [Abstract][Full Text] [Related]
28. Retina-specific loss of
Ueki Y; Shchepetkina V; Lefcort F
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29929962
[TBL] [Abstract][Full Text] [Related]
29. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Oct; 310(2):627-33. PubMed ID: 14521957
[TBL] [Abstract][Full Text] [Related]
30. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
Liu B; Anderson SL; Qiu J; Rubin BY
FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
[TBL] [Abstract][Full Text] [Related]
31. Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells.
Keren H; Donyo M; Zeevi D; Maayan C; Pupko T; Ast G
PLoS One; 2010 Dec; 5(12):e15884. PubMed ID: 21209961
[TBL] [Abstract][Full Text] [Related]
32. Nutraceutical-mediated restoration of wild-type levels of IKBKAP-encoded IKAP protein in familial dysautonomia-derived cells.
Anderson SL; Liu B; Qiu J; Sturm AJ; Schwartz JA; Peters AJ; Sullivan KA; Rubin BY
Mol Nutr Food Res; 2012 Apr; 56(4):570-9. PubMed ID: 22495984
[TBL] [Abstract][Full Text] [Related]
33. Rescue of a human mRNA splicing defect by the plant cytokinin kinetin.
Slaugenhaupt SA; Mull J; Leyne M; Cuajungco MP; Gill SP; Hims MM; Quintero F; Axelrod FB; Gusella JF
Hum Mol Genet; 2004 Feb; 13(4):429-36. PubMed ID: 14709595
[TBL] [Abstract][Full Text] [Related]
34. Genomic organization and chromosomal localization of the mouse IKBKAP gene.
Coli R; Anderson SL; Volpi SA; Rubin BY
Gene; 2001 Nov; 279(1):81-9. PubMed ID: 11722848
[TBL] [Abstract][Full Text] [Related]
35. IKAP deficiency in an FD mouse model and in oligodendrocyte precursor cells results in downregulation of genes involved in oligodendrocyte differentiation and myelin formation.
Cheishvili D; Dietrich P; Maayan C; Even A; Weil M; Dragatsis I; Razin A
PLoS One; 2014; 9(4):e94612. PubMed ID: 24760006
[TBL] [Abstract][Full Text] [Related]
36. Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.
Cheishvili D; Maayan C; Holzer N; Tsenter J; Lax E; Petropoulos S; Razin A
J Mol Neurosci; 2016 Jul; 59(3):382-91. PubMed ID: 27129499
[TBL] [Abstract][Full Text] [Related]
37. Cloning, characterization, and genomic structure of the mouse Ikbkap gene.
Cuajungco MP; Leyne M; Mull J; Gill SP; Gusella JF; Slaugenhaupt SA
DNA Cell Biol; 2001 Sep; 20(9):579-86. PubMed ID: 11747609
[TBL] [Abstract][Full Text] [Related]
38. Dynamic changes in IKBKAP mRNA levels during crisis of familial dysautonomia patients.
Cheishvili D; Laiba E; Rekhtman D; Claman A; Razin A; Maayan C
Auton Neurosci; 2014 Feb; 180():59-65. PubMed ID: 24268683
[TBL] [Abstract][Full Text] [Related]
39. Founder mutation in IKBKAP gene causes vestibular impairment in familial dysautonomia.
Gutiérrez JV; Kaufmann H; Palma JA; Mendoza-Santiesteban C; Macefield VG; Norcliffe-Kaufmann L
Clin Neurophysiol; 2018 Feb; 129(2):390-396. PubMed ID: 29289840
[TBL] [Abstract][Full Text] [Related]
40. IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia.
Dietrich P; Alli S; Shanmugasundaram R; Dragatsis I
Hum Mol Genet; 2012 Dec; 21(23):5078-90. PubMed ID: 22922231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
